Advertisement

Topics

Acasti Pharma Inc.: Acasti Pharma Reports Third Quarter FY 2018 Financial Results

17:04 EST 13 Feb 2018 | FinanzNachrichten

LAVAL, QUEBEC -- (Marketwired) -- 02/13/18 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its p...

Original Article: Acasti Pharma Inc.: Acasti Pharma Reports Third Quarter FY 2018 Financial Results

NEXT ARTICLE

More From BioPortfolio on "Acasti Pharma Inc.: Acasti Pharma Reports Third Quarter FY 2018 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...